Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEP domain containing 1 pseudogene 2 (DEPDC1P2) is a pseudogene in humans, meaning it is a genomic DNA sequence similar to DEPDC1 but does not encode a functional protein or have a direct biological function. It is not known to play an active role in any molecular pathways or diseases, nor is it targeted by therapeutic drugs[4][7][10]. DEPDC1P2 is explicitly indicated as a pseudogene, differentiating it from DEPDC1, which is a functional gene implicated in cancer biology and as a possible therapeutic target in multiple tumors[3][4][6][9]. Pseudogenes like DEPDC1P2 are typically non-coding and lack established molecular, functional, or disease-associated roles[4][7]. DEPDC1P2 is not a molecule or receptor with therapeutic relevance, has no aliases or interacting drugs, does not encode a protein, and represents a non-functional copy of the DEP domain containing 1 gene. For research queries about cancer targets, refer to its functional relative, DEPDC1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEP domain containing 1 pseudogene 2 (DEPDC1P2).